Zinc oxide nanoparticles (ZnO NPs) combined with cisplatin and gemcitabine inhibits tumor activity of NSCLC cells

Chenping Hu; Wenxiu Du

doi:doi:10.18632/aging.104187

← Back

This article is currently undergoing investigation.

Research Paper Volume 12, Issue 24 pp 25767—25777

Zinc oxide nanoparticles (ZnO NPs) combined with cisplatin and gemcitabine inhibits tumor activity of NSCLC cells

Figure 5. The GSH levels in ZnO-NPs, Cp, Gem, Cp+Gem, ZnO-NPs(Cp), ZnO-NPs(Gem) and ZnO NPs(Cp/Gem) groups is tested using GSH kit. * P< 0.05 vs. Control. # P< 0.05 vs. Cp, Gem, ZnO-NPs(Cp), or ZnO-NPs(Gem) groups.